195 related articles for article (PubMed ID: 6716096)
1. Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder.
Beeber AR; Kline MD; Pies RW; Manring JM
J Nerv Ment Dis; 1984 May; 172(5):301-3. PubMed ID: 6716096
[TBL] [Abstract][Full Text] [Related]
2. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
[TBL] [Abstract][Full Text] [Related]
3. The dexamethasone suppression test in patients with borderline personality disorders.
Soloff PH; George A; Nathan RS
Am J Psychiatry; 1982 Dec; 139(12):1621-3. PubMed ID: 7149068
[No Abstract] [Full Text] [Related]
4. The dexamethasone suppression test in borderlines: is it useful?
Korzekwa M; Steiner M; Links P; Eppel A
Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
[TBL] [Abstract][Full Text] [Related]
5. The dexamethasone suppression test in borderline personality disorder.
Krishnan KR; Davidson JR; Rayasam K; Shope F
Biol Psychiatry; 1984 Jul; 19(7):1149-53. PubMed ID: 6477995
[No Abstract] [Full Text] [Related]
6. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
Baxter L; Edell W; Gerner R; Fairbanks L; Gwirtsman H
J Clin Psychiatry; 1984 Apr; 45(4):150-3. PubMed ID: 6715286
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
[TBL] [Abstract][Full Text] [Related]
8. The interface between borderline personality disorder and affective disorder.
Gunderson JG; Elliott GR
Am J Psychiatry; 1985 Mar; 142(3):277-88. PubMed ID: 2857532
[TBL] [Abstract][Full Text] [Related]
9. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder.
Lahmeyer HW; Val E; Gaviria FM; Prasad RB; Pandey GN; Rodgers P; Weiler MA; Altman EG
Psychiatry Res; 1988 Jul; 25(1):19-30. PubMed ID: 3217463
[TBL] [Abstract][Full Text] [Related]
10. History of suicidal behavior in depressed borderline inpatients.
Friedman RC; Aronoff MS; Clarkin JF; Corn R; Hurt SW
Am J Psychiatry; 1983 Aug; 140(8):1023-6. PubMed ID: 6869585
[TBL] [Abstract][Full Text] [Related]
11. Characterizing depression in borderline patients.
Soloff PH; George A; Nathan RS; Schulz PM
J Clin Psychiatry; 1987 Apr; 48(4):155-7. PubMed ID: 3558327
[TBL] [Abstract][Full Text] [Related]
12. Depression, borderline disorder, and the DST.
Am J Psychiatry; 1983 Jun; 140(6):818-20. PubMed ID: 6846653
[No Abstract] [Full Text] [Related]
13. Neuroendocrine evaluation of depression in borderline patients.
Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
[No Abstract] [Full Text] [Related]
14. Distinguishing subtypes within the borderline domain: a combined psychoneuroendocrine approach.
Steiner M; Martin S; Wallace JE; Goldman S
Biol Psychiatry; 1984 Jun; 19(6):907-11. PubMed ID: 6743724
[No Abstract] [Full Text] [Related]
15. Study of the diagnostic value of the dexamethasone suppression test in endogenous depression.
Aguilar MT; Lemaire M; Castro P; Libotte M; Reynders J; Herchuelz A
J Affect Disord; 1984 Feb; 6(1):33-42. PubMed ID: 6231328
[TBL] [Abstract][Full Text] [Related]
16. Is bulimia associated with borderline personality disorder? A controlled study.
Pope HG; Frankenburg FR; Hudson JI; Jonas JM; Yurgelun-Todd D
J Clin Psychiatry; 1987 May; 48(5):181-4. PubMed ID: 3571171
[TBL] [Abstract][Full Text] [Related]
17. The DST in borderline patients.
Dilsaver SC; Greden JF
Am J Psychiatry; 1983 Nov; 140(11):1540-1. PubMed ID: 6625014
[No Abstract] [Full Text] [Related]
18. The validity of the dexamethasone suppression test as a marker for endogenous depression.
Zimmerman M; Coryell W; Pfohl B
Arch Gen Psychiatry; 1986 Apr; 43(4):347-55. PubMed ID: 3954557
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three systems for diagnosing borderline personality disorder.
Nelson HF; Tennen H; Tasman A; Borton M; Kubeck M; Stone M
Am J Psychiatry; 1985 Jul; 142(7):855-8. PubMed ID: 4014508
[TBL] [Abstract][Full Text] [Related]
20. TRH stimulation and dexamethasone suppression in borderline personality disorder.
De la Fuente JM; Mendlewicz J
Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]